These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25425197)

  • 1. Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation.
    De Falco F; Sabatini R; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Del Papa B; Screpanti I; Marconi P; Rosati E
    Leukemia; 2015 Apr; 29(4):994-8. PubMed ID: 25425197
    [No Abstract]   [Full Text] [Related]  

  • 2. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.
    Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S
    Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.
    Onaindia A; Gómez S; Piris-Villaespesa M; Martínez-Laperche C; Cereceda L; Montes-Moreno S; Batlle A; de Villambrosia SG; Pollán M; Martín-Acosta P; González-Rincón J; Menarguez J; Alvés J; Rodriguez-Pinilla SM; García JF; Mollejo M; Fraga M; García-Marco JA; Piris MA; Sánchez-Beato M
    Haematologica; 2015 May; 100(5):e200-3. PubMed ID: 25552700
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.
    Palomero T; Sulis ML; Cortina M; Real PJ; Barnes K; Ciofani M; Caparros E; Buteau J; Brown K; Perkins SL; Bhagat G; Agarwal AM; Basso G; Castillo M; Nagase S; Cordon-Cardo C; Parsons R; Zúñiga-Pflücker JC; Dominguez M; Ferrando AA
    Nat Med; 2007 Oct; 13(10):1203-10. PubMed ID: 17873882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
    Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
    Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.
    Rasi S; Khiabanian H; Ciardullo C; Terzi-di-Bergamo L; Monti S; Spina V; Bruscaggin A; Cerri M; Deambrogi C; Martuscelli L; Biasi A; Spaccarotella E; De Paoli L; Gattei V; Foà R; Rabadan R; Gaidano G; Rossi D
    Haematologica; 2016 Apr; 101(4):e135-8. PubMed ID: 26819056
    [No Abstract]   [Full Text] [Related]  

  • 7. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
    Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
    Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common nonmutational
    Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.
    De Falco F; Rompietti C; Sorcini D; Esposito A; Scialdone A; Baldoni S; Del Papa B; Adamo FM; Silva Barcelos EC; Dorillo E; Stella A; Di Ianni M; Screpanti I; Sportoletti P; Rosati E
    Cell Death Dis; 2022 Sep; 13(9):755. PubMed ID: 36050315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1.
    Liu ZJ; Xiao M; Balint K; Soma A; Pinnix CC; Capobianco AJ; Velazquez OC; Herlyn M
    FASEB J; 2006 May; 20(7):1009-11. PubMed ID: 16571776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished interaction between mutant NOTCH1 and the NuRD corepressor complex upregulates CCL17 in chronic lymphocytic leukemia.
    Wang S; Ge M; Cui J; Qiao Z; Chen X; Wu S; Zhan R; Zhou H; Liu H; Xu Z
    Leukemia; 2019 Dec; 33(12):2951-2956. PubMed ID: 31341237
    [No Abstract]   [Full Text] [Related]  

  • 12. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
    Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
    Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
    Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
    Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation.
    Blalock WL; Grimaldi C; Fala F; Follo M; Horn S; Basecke J; Martinelli G; Cocco L; Martelli AM
    J Cell Physiol; 2009 Oct; 221(1):232-41. PubMed ID: 19507191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.
    Shimizu T; Kagawa T; Inoue T; Nonaka A; Takada S; Aburatani H; Taga T
    Mol Cell Biol; 2008 Dec; 28(24):7427-41. PubMed ID: 18852283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia.
    McGovern B; Quinn F; Andrews C; Jeffers M; Bacon CL; Bird B; Crotty G; Vandenberghe E; Flavin R
    Leuk Lymphoma; 2017 Mar; 58(3):732-735. PubMed ID: 27686521
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase B/Akt phosphorylates and inhibits the cardiac Na+/H+ exchanger NHE1.
    Snabaitis AK; Cuello F; Avkiran M
    Circ Res; 2008 Oct; 103(8):881-90. PubMed ID: 18757828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of PI3K-Akt-GSK3β signaling pathway in U251 cells by risperidone].
    Liang L; Wang Y; Wei J; Gu X; Xiang B; Ma X; Li T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Dec; 31(6):693-7. PubMed ID: 25449069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.